LBO — LOS ANGELES GENERAL MEDICAL CENTER
IRR: 17.3% | MOIC: 2.22x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
17.3%
IRR
2.22x
MOIC
$2.0B
Entry EV
$3.2B
Exit EV
$1.1B
Equity Invested
Sources & Uses
S&UTotal · $2.0B| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $795.9M | 38.8% | |
| Sub Debt | $199.0M | 9.7% | |
| Equity | $1.1B | 51.5% | |
| Enterprise Value | $2.0B | 97.1% | |
| Transaction Fees | $59.7M | 2.9% | |
| Total Uses | $2.0B | 100.0% |
Interpretation
INTAt 2.22x MOIC and 17.3% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $301.7M |
| Exit Ev | $3.2B |
| Net Debt At Exit | $829.4M |
| Equity At Exit | $2.3B |
| Equity Invested | $1.1B |
| Total Value Created | $1.3B |
| Value From Growth | $1.1B |
| Value From Multiple | $99.5M |
| Value From Deleveraging | $165.5M |